These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9336674)

  • 1. Management of asymptomatic term neonates whose mothers received intrapartum antibiotics--Part 1: Rationale for intrapartum antibiotic therapy.
    Allen SR
    Clin Pediatr (Phila); 1997 Oct; 36(10):563-8. PubMed ID: 9336674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of asymptomatic term neonates whose mothers received intrapartum antibiotics--Part 2: Diagnostic tests and management strategies. Center of Disease Control and Prevention.
    Allen SR
    Clin Pediatr (Phila); 1997 Nov; 36(11):617-24. PubMed ID: 9391735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of fever in labor and risk of neonatal sepsis.
    Towers CV; Yates A; Zite N; Smith C; Chernicky L; Howard B
    Am J Obstet Gynecol; 2017 Jun; 216(6):596.e1-596.e5. PubMed ID: 28216060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of group B streptococcus early-onset sepsis in term neonates with second-line prophylaxis maternal intrapartum antibiotics: a multicenter retrospective study.
    Low JM; Lee JH; Foote HP; Hornik CP; Clark RH; Greenberg RG
    Am J Obstet Gynecol; 2024 Jun; 230(6):673.e1-673.e8. PubMed ID: 37890649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.
    Pylipow M; Gaddis M; Kinney JS
    Pediatrics; 1994 Apr; 93(4):631-5. PubMed ID: 8134220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of group b streptococcus vertical transmission].
    Andreu Domingo A; Salcedo Abizanda S; Heredia Prim F; González Morlans J; Bartolomé Comas RM; Cabero Roura L
    An Esp Pediatr; 1997 Apr; 46(4):383-8. PubMed ID: 9214233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers.
    Glasgow TS; Speakman M; Firth S; James B; Byington CL; Young PC
    Paediatr Perinat Epidemiol; 2007 Jul; 21(4):338-46. PubMed ID: 17564591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy in neonates whose mothers have received intrapartum group B streptococcal chemoprophylaxis.
    Baker CJ
    Pediatr Infect Dis J; 1990 Feb; 9(2):149-50. PubMed ID: 2179842
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis.
    Ascher DP; Becker JA; Yoder BA; Weisse M; Waecker NJ; Heroman WM; Davis C; Fajardo JE; Fischer GW
    J Perinatol; 1993; 13(3):212-6. PubMed ID: 8345385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of perinatal infection caused by group B beta-hemolytic streptococcus].
    Bevilacqua G
    Acta Biomed Ateneo Parmense; 1999; 70(5-6):87-94. PubMed ID: 11402819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of group B streptococcal infection.
    Noya FJ; Baker CJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
    Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of 168 neonates weighing more than 2000 g receiving intrapartum chemoprophylaxis for chorioamnionitis. Evaluation of an early discharge strategy.
    Singhal KK; La Gamma EF
    Arch Pediatr Adolesc Med; 1996 Feb; 150(2):158-63. PubMed ID: 8556119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin.
    Joseph TA; Pyati SP; Jacobs N
    Arch Pediatr Adolesc Med; 1998 Jan; 152(1):35-40. PubMed ID: 9452705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapartum antibiotic prophylaxis for Group B Streptococcus: has the time come to wait more than 4 hours?
    Turrentine M
    Am J Obstet Gynecol; 2014 Jul; 211(1):15-7. PubMed ID: 24315859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants.
    Bromberger P; Lawrence JM; Braun D; Saunders B; Contreras R; Petitti DB
    Pediatrics; 2000 Aug; 106(2 Pt 1):244-50. PubMed ID: 10920146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.